Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A cash flow conversion efficiency. Based on the latest financial reports, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.54 Million ≈ $3.88 Million USD) by net assets (CN¥1.69 Billion ≈ $246.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)

Cash flow conversion efficiency of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shaanxi Panlong Pharmaceutical Group Lim (002864) share price today for real-time trading data and today's change.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Cash Flow Conversion Ratio Explained

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A ranked by their cash flow conversion efficiency. Also see Shaanxi Panlong Pharmaceutical Group Lim market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
cBrain A/S
CO:CBRAIN
0.133x
Yuen Foong Yu Consumer Prod
TW:6790
0.071x
BH Co Ltd
KQ:090460
0.352x
Haymaker Acquisition Corp. 4
NYSE:HYAC
-0.215x
Seanergy Maritime Holdings Corp
NASDAQ:SHIP
0.101x
ADF Foods Limited
NSE:ADFFOODS
0.056x
Picpay Holdings Netherlands N.V. Class A Common Shares
NASDAQ:PICS
0.736x
Fiverr International Ltd
NYSE:FVRR
0.032x

Annual Cash Flow Conversion Efficiency for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. Review 002864 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.69 Billion
≈ $247.16 Million
CN¥63.01 Million
≈ $9.22 Million
0.037x -61.00%
2024-12-31 CN¥1.64 Billion
≈ $239.57 Million
CN¥156.59 Million
≈ $22.91 Million
0.096x +42.60%
2023-12-31 CN¥1.55 Billion
≈ $227.00 Million
CN¥104.05 Million
≈ $15.23 Million
0.067x -49.30%
2022-12-31 CN¥947.60 Million
≈ $138.66 Million
CN¥125.36 Million
≈ $18.34 Million
0.132x -7.97%
2021-12-31 CN¥807.21 Million
≈ $118.12 Million
CN¥116.04 Million
≈ $16.98 Million
0.144x +14.65%
2020-12-31 CN¥735.66 Million
≈ $107.65 Million
CN¥92.24 Million
≈ $13.50 Million
0.125x +24.61%
2019-12-31 CN¥674.71 Million
≈ $98.73 Million
CN¥67.89 Million
≈ $9.93 Million
0.101x +31.36%
2018-12-31 CN¥611.60 Million
≈ $89.50 Million
CN¥46.85 Million
≈ $6.86 Million
0.077x +49.58%
2017-12-31 CN¥555.58 Million
≈ $81.30 Million
CN¥28.45 Million
≈ $4.16 Million
0.051x -72.92%
2016-12-31 CN¥327.82 Million
≈ $47.97 Million
CN¥61.99 Million
≈ $9.07 Million
0.189x +34.49%
2015-12-31 CN¥288.89 Million
≈ $42.27 Million
CN¥40.62 Million
≈ $5.94 Million
0.141x -28.71%
2014-12-31 CN¥246.19 Million
≈ $36.03 Million
CN¥48.56 Million
≈ $7.11 Million
0.197x +63.50%
2013-12-31 CN¥210.84 Million
≈ $30.85 Million
CN¥25.43 Million
≈ $3.72 Million
0.121x --

About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

SHE:002864 China Drug Manufacturers - Specialty & Generic
Market Cap
$313.38 Million
CN¥2.14 Billion CNY
Market Cap Rank
#14349 Global
#4241 in China
Share Price
CN¥20.15
Change (1 day)
+0.55%
52-Week Range
CN¥19.41 - CN¥39.20
All Time High
CN¥74.44
About

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chine… Read more